Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia

Cited by (818)

Items 301–400 of 818

1. Frontotemporal Dementia in Elderly Individuals
   Atik Baborie, Timothy David Griffiths, Evelyn Jaros, Parastoo Momeni, Ian Grant McKeith, David John Burn, Geoffrey Keir, Andrew J. Larner, David M. A. Mann, Robert Perry · 2012 · Archives of Neurology
2. α-Synuclein interferes with the ESCRT-III complex contributing to the pathogenesis of Lewy body disease
   Brian J. Spencer, Changyoun Kim, Tania Gonzalez, Alejandro Bisquertt, Christina Patrick, Edward M. Rockenstein, Anthony Adame, Seung‐Jae Lee, Paula Desplats, Eliezer Masliah · 2016 · Human Molecular Genetics
3. Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions
   Justus C. Dächsel, Owen A. Ross, Ignacio Fernandez Mata, Jennifer M. Kachergus, Mathias Toft, Ashley D. Cannon, Matt C. Baker, Jennifer L. Adamson, Mike Hutton, Dennis W. Dickson et al. · 2006 · Acta Neuropathologica
4. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: a longitudinal arterial spin labeling study
   Dopper, Elise G.P., Chalos, Vicky, Ghariq, Eidrees, den Heijer, Tom, Hafkemeijer, Anne, Jiskoot, Lize C., de Koning, Inge, Seelaar, Harro, van Minkelen, Rick, van Osch, Matthias J.P. et al. · 2016 · NeuroImage: Clinical
5. Progranulin and TDP-43: Mechanistic Links and Future Directions
   Samir Kumar‐Singh · 2011 · Journal of Molecular Neuroscience
6. Tau is central in the genetic Alzheimer–frontotemporal dementia spectrum
   Bart Dermaut, Samir Kumar‐Singh, Rosa Rademakers, Jessie Theuns, Marc Cruts, Christine Van Broeckhoven · 2005 · Trends in Genetics
7. Identification of 2 Loci at Chromosomes 9 and 14 in a Multiplex Family With Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
   Ilse Gijselinck, Sebastiaan Engelborghs, Githa Maes, Ivy Cuijt, Karin Peeters, Maria Mattheijssens, Geert Joris, Patrick P Cras, Jean‐Jacques Martin, Peter P. De Deyn et al. · 2010 · Archives of Neurology
8. Genetics and Underlying Pathology of Dementia
   Beata Ferencz, Lotte Gerritsen · 2015 · Neuropsychology Review
9. Recent insights into the molecular genetics of dementia
   Rosa Rademakers, Anne Rovelet‐Lecrux · 2009 · Trends in Neurosciences
10. Research Advances in Amyotrophic Lateral Sclerosis, 2009 to 2010
    Rebecca Traub, Hiroshi Mitsumoto, Lewis P. Rowland · 2010 · Current Neurology and Neuroscience Reports
11. Type-Dependent Oxidative Damage in Frontotemporal Lobar Degeneration: Cortical Astrocytes Are Targets of Oxidative Damage
    Anna Martínez, Margarita Carmona, Manuel Portero‐Otín, Alba Naudí, Reinald Pamplona, Isidró Ferrer · 2008 · Journal of Neuropathology & Experimental Neurology
12. Pik3c3 deletion in pyramidal neurons results in loss of synapses, extensive gliosis and progressive neurodegeneration
    Liang-Li Wang, Katie Budolfson, Fan Wang · 2010 · Neuroscience
13. The Emerging Roles of MicroRNAs in the Pathogenesis of Frontotemporal Dementia–Amyotrophic Lateral Sclerosis (FTD-ALS) Spectrum Disorders
    Eduardo Gascon, Fen‐Biao Gao · 2014 · Journal of Neurogenetics
14. Abnormal regulation of TSG101 in mice with spongiform neurodegeneration
    Jian Jiao, Kaihua Sun, Will P. Walker, Pooneh Bagher, Christina D. Cota, Teresa M. Gunn · 2009 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
15. The ESCRT protein CHMP2B acts as a diffusion barrier on reconstituted membrane necks
    Nicola De Franceschi, Maryam Alqabandi, Nolwenn Miguet, Christophe Caillat, Stéphanie Mangenot, Winfríed Weissenhorn, Patricia M. Bassereau · 2018 · Journal of Cell Science
16. The genetics of frontotemporal lobar degeneration
    Rosa Rademakers, Mike Hutton · 2007 · Current Neurology and Neuroscience Reports
17. Clinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review
    Xiaodong Pan, Xiaochun Chen · 2013 · Translational Neurodegeneration
18. Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical series
    Barbara Borroni, Silvana Archetti, Antonella Alberici, Chiara Agosti, Massimo Gennarelli, Barbara Bigni, Cristian Bonvicini, Maria Ferrari, Giuseppe Bellelli, Daniela Galimberti et al. · 2008 · Neurogenetics
19. Pilot whole-exome sequencing of a German early-onset Alzheimer's disease cohort reveals a substantial frequency of PSEN2 variants
    Cornelis Blauwendraat, Carlo Wilke, Iris E. Jansen, Claudia Schulte, Javier Simón‐Sánchez, Florian Gerhard Metzger, Benjamin Bender, Thomas Gasser, Walter Maetzler, Patrizia Rizzu et al. · 2015 · Neurobiology of Aging
20. The Genetics of Monogenic Frontotemporal Dementia
    Leonel Tadao Takada · 2015 · Dementia & Neuropsychologia
21. Prion‐like propagation as a pathogenic principle in frontotemporal dementia
    Eva‐Maria Hock, Magdalini Polymenidou · 2016 · Journal of Neurochemistry
22. Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis
    Chris Ugbode, Ryan J. H. West · 2020 · Neurobiology of Disease
23. Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions
    Keith A. Josephs, Wen-Lang Lin, Zeshan Ahmed, David Alexander Stroh, Neill R. Graff‐Radford, Dennis W. Dickson · 2008 · Acta Neuropathologica
24. Inferred divergent gene regulation in archaic hominins reveals potential phenotypic differences
    Colbran, Laura L., Gamazon, Eric R., Zhou, Dan, Evans, Patrick, Cox, Nancy J., Capra, John A. · 2019 · Nature Ecology & Evolution
25. Activation of calcineurin is mainly responsible for the calcium sensitivity of gene deletion mutations in the genome of budding yeast
    Yunying Zhao, Jingcai Du, Gang Zhao, Linghuo Jiang · 2012 · Genomics
26. Genetic Variability in CHMP2B and Frontotemporal Dementia
    Parastoo Momeni, Ekaterina A. Rogaeva, Vivianna M. Van Deerlin, Wuxing Yuan, Jordan Henry Grafman, Michael Tierney, Edward D. Huey, Jason Bell, Christopher M. Morris, Raj N. Kalaria et al. · 2006 · Neurodegenerative Diseases
27. Frontotemporal lobar degeneration genome wide association study replication confirms a risk locus shared with amyotrophic lateral sclerosis
    Sara J. Rollinson, Simon Mead, Julie S. Snowden, Anna M. T. Richardson, Jonathan Daniel Rohrer, Nicola A. Halliwell, Suzanne Usher, D. Neary, David M. A. Mann, John Hardy et al. · 2011 · Neurobiology of Aging
28. Genetics of dementia: Update and guidelines for the clinician
    Petra E. Cohn‐Hokke, Mariet W. Elting, Yolande A.L. Pijnenburg, John Cornelis Van Swieten · 2012 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
29. TDP-43 in neurodegenerative disorders
    Casey N. Cook, Yong‐Jie Zhang, Ya-Fei Xu, Dennis W. Dickson, Leonard Petrucelli · 2008 · Expert Opinion on Biological Therapy
30. Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease
    Satra Nim, Darren M. O’Hara, Carles Corbi‐Verge, Albert Perez‐Riba, Kazuko Fujisawa, Minesh Kapadia, Hien Chau, Federica Albanese, Grishma N. Pawar, Mitchell L. de Snoo et al. · 2023 · Nature Communications
31. The autophagy-lysosomal pathway
    Daniel L. Kenney‐Jung, Eduardo Elias Benarroch · 2015 · Neurology
32. The role of CHMP2BIntron5 in autophagy and frontotemporal dementia
    Christopher S. Krasniak, Syed Tariq Ahmad · 2016 · Brain Research
33. Gene expression in nanotoxicology research: Analysis by differential display in BALB3T3 fibroblasts exposed to cobalt particles and ions
    Elena Papis, Rosalba Gornati, Mariangela Prati, Jessica Ponti, Enrico Sabbioni, Giovanni Bernardini · 2007 · Toxicology Letters
34. Characterization of Ubiquitinated Intraneuronal Inclusions in a Novel Belgian Frontotemporal Lobar Degeneration Family
    Daniel Nicolae Pirici, Rik R. Vandenberghe, Rosa Rademakers, Bart Dermaut, Marc Cruts, Krist’l Vennekens, Ivy Cuijt, Ursula Lübke, C. Ceuterick, Jean‐Jacques Martin et al. · 2006 · Journal of Neuropathology & Experimental Neurology
35. The molecular genetics of non-ALS motor neuron diseases
    Paul Andrew James, Kevin Talbot · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
36. Hypertonia-Associated Protein Trak1 Is a Novel Regulator of Endosome-to-Lysosome Trafficking
    Elizabeth A. Webber, Lian Li, Lih‐Shen Chin · 2008 · Journal of Molecular Biology
37. The endolysosomal pathway and ALS/FTD
    Tiffany W. Todd, Wei Shao, Yong‐Jie Zhang, Leonard Petrucelli · 2023 · Trends in Neurosciences
38. Neuronal Autophagy: Regulations and Implications in Health and Disease
    Liénard, Caroline, Pintart, Alexandre, Bomont, Pascale · 2024 · Cells
39. Valosin Containing Protein Associated Fronto-Temporal Lobar Degeneration: Clinical Presentation, Pathologic Features and Pathogenesis
    Conrad C. Weihl · 2011 · Current Alzheimer Research
40. Mahogunin regulates fusion between amphisomes/MVBs and lysosomes via ubiquitination of TSG101
    P Majumder, Oishee Chakrabarti · 2015 · Cell Death and Disease
41. Genetics of frontotemporal lobar degeneration: An up-date and diagnosis algorithm
    Isabelle Le Ber · 2013 · Revue Neurologique
42. Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation
    Nadia D’Ambrosi, Mauro Cozzolino, Maria Teresa Carrı̀ · 2017 · Antioxidants and Redox Signaling
43. Frontotemporal dementia causative CHMP2B impairs neuronal endolysosomal traffic-rescue byTMEM106Bknockdown
    Emma L. Clayton, Carmelo Milioto, Bhavana Muralidharan, Frances E. Norona, James R. Edgar, Armand Soriano, Paymaan Jafar‐Nejad, Frank Rigo, John Collinge, Adrian M. Isaacs · 2018 · Brain
44. Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansion
    Jamie C Fong, Anna M. Karydas, Jill S. Goldman · 2012 · Alzheimer s Research & Therapy
45. The role of ESCRT during development and functioning of the nervous system
    Rémy Sadoul, Marine H. Laporte, Romain Chassefeyre, Kwang Il, Yves Goldberg, Christine Chatellard, Fiona J. Hemming, Sandrine Fraboulet · 2017 · Seminars in Cell and Developmental Biology
46. Clinical and genetic analysis of MAPT, GRN, and C9orf72 genes in Korean patients with frontotemporal dementia
    Eun‐Joo Kim, Jay Cheol Kwon, Kee Hyung Park, Kyung-Won Park, Jae‐Hong Lee, Seong Hye Choi, Jee Hyang Jeong, Byeong Chae Kim, Soo Jin Yoon, Young Chul Yoon et al. · 2013 · Neurobiology of Aging
47. Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland
    Anna-Lotta Kaivorinne, Johanna Krüger, Katja Kuivaniemi, Hannu J. Tuominen, Virpi Moilanen, Kari Majamaa, Anne Marja Remes · 2008 · BMC Neurology
48. Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis
    Suvi Häkkinen, Stephanie A. Chu, Suzee E. Lee · 2020 · Neurobiology of Disease
49. Frontotemporal Lobar Degeneration
    Keith A. Josephs · 2007 · Neurologic Clinics
50. MITD1 is recruited to midbodies by ESCRT-III and participates in cytokinesis
    Seongju Lee, Jaerak Chang, Benoît Renvoisé, Anita Tipirneni, Sarah P. Yang, Craig D. Blackstone · 2012 · Molecular Biology of the Cell
51. Frontotemporal dementia linked to chromosome 3 (FTD‐3) – current concepts and the detection of a previously unknown branch of the Danish FTD‐3 family
    Suzanne Granhøj Lindquist, Hans Brændgaard, Kirsten Svenstrup, Adrian M. Isaacs, Jørgen Erik Nielsen · 2008 · European Journal of Neurology
52. Indexing Effects of Copy Number Variation on Genes Involved in Developmental Delay
    Mohammed J. Uddin, Giovanna Pellecchia, Bhooma Thiruvahindrapuram, Lia D’Abate, Daniele Merico, Ada J. S. Chan, Mehdi Zarrei, Kristiina Tammimies, Susan Walker, Matthew J. Gazzellone et al. · 2016 · Scientific Reports
53. Caenorhabditis elegans: A transgenic model for studying age-associated neurodegenerative diseases
    Nisha Rani, Mohammad Mumtaz Alam, Azfar Jamal, Usama Bin Ghaffar, Suhel Parvez · 2023 · Ageing Research Reviews
54. Molecular Pathways of Frontotemporal Lobar Degeneration
    Kristel Sleegers, Marc Cruts, Christine Van Broeckhoven · 2010 · Annual Review of Neuroscience
55. Astrocytic reactivity triggered by defective autophagy and metabolic failure causes neurotoxicity in frontotemporal dementia type 3
    Abinaya Chandrasekaran, Katarina Stoklund Dittlau, Giulia Ilaria Corsi, Henriette Haukedal, Nadezhda T. Doncheva, Sarayu Ramakrishna, Sheetal Ambardar, Claudia Salcedo, Sissel Ida Schmidt, Yu Zhang et al. · 2021 · Stem Cell Reports
56. Novel Types of Frontotemporal Lobar Degeneration: Beyond Tau and TDP-43
    Ian R. Mackenzie, Manuela Neumann, Nigel J. Cairns, David G. Muñoz, Adrian M. Isaacs · 2011 · Journal of Molecular Neuroscience
57. Modelling amyotrophic lateral sclerosis in rodents
    Tiffany W. Todd, Leonard Petrucelli · 2022 · Nature reviews. Neuroscience
58. Update on Recent Molecular and Genetic Advances in Frontotemporal Lobar Degeneration
    Eileen H. Bigio · 2008 · Journal of Neuropathology & Experimental Neurology
59. Progranulin: An emerging target for FTLD therapies
    Jennifer M. Gass, Mercedes Prudencio, Caroline T. Stetler, Leonard Petrucelli · 2012 · Brain Research
60. WDR41 supports lysosomal response to changes in amino acid availability
    Amick, Joseph, Tharkeshwar, Arun Kumar, Amaya,, Catherine, Ferguson, Shawn M. · 2018 · Molecular Biology of the Cell
61. Frontotemporal lobar degeneration: current knowledge and future challenges
    Chiara Cerami, Elio Angelo Scarpini, Stefano Francesco Cappa, Daniela Galimberti · 2012 · Journal of Neurology
62. Progranulin
    Ryan A. Townley, Bradley F. Boeve, Eduardo Elias Benarroch · 2017 · Neurology
63. Stop-gain mutations in UBAP1 cause pure autosomal-dominant spastic paraplegia
    Xiang Lin, Hui‐Zhen Su, En‐Lin Dong, Xiao-Hong Lin, Miao Zhao, Can Yang, Chong Wang, Jie Wang, Yi-Jun Chen, Hongjie Yu et al. · 2019 · Brain
64. No association of TDP-43 with sporadic frontotemporal dementia
    Axel Schumacher, Patricia Friedrich, Janine Diehl‐Schmid, Bernd Ibach, Robert Perneczky, Tamara Eisele, Ruth Vukovich, Hans Förstl, Markus J. Riemenschneider · 2007 · Neurobiology of Aging
65. Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration
    Sara J. Rollinson, Patrizia Rizzu, Stephen K. Sikkink, Matthew Baker, Nicola A. Halliwell, Julie S. Snowden, Bryan J. Traynor, Dina Ruano, Nigel J. Cairns, Jonathan Daniel Rohrer et al. · 2009 · Neurobiology of Aging
66. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III
    Mi-Hee Jun, Jeong Ho Han, Yu-Kyung Lee, Deok‐Jin Jang, Bong‐Kiun Kaang, Jin‐A Lee · 2015 · Molecular Brain
67. Tauopathy and Movement Disorders—Unveiling the Chameleons and Mimics
    Jacky Ganguly, Mandar Jog · 2020 · Frontiers in Neurology
68. Characterization of the 3p12.3‐pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer
    Neal A. L. Cody, Zhen Shen, Jean‐Sébastien Ripeau, Diane Michele Provencher, Anne‐Marie Mes‐Masson, Mario Chevrette, Patricia N. Tonin · 2009 · Molecular Carcinogenesis
69. Genetics of Frontotemporal Lobar Degeneration
    Daniela Galimberti, Elio Angelo Scarpini · 2012 · Frontiers in Neurology
70. The novel Tau mutation G335S: clinical, neuropathological and molecular characterization
    Salvatore Spina, Jill R. Murrell, Hirotaka Yoshida, Bernardino Francesco Ghetti, Niamh Bermingham, Brian J. Sweeney, Stephen R. Dlouhy, R. Anthony Crowther, Michel Goedert, Catherine Keohane · 2006 · Acta Neuropathologica
71. CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia
    Patrizia Rizzu, Saskia E. van Mil, Burcu Anar, Sonia M. Rosso, Laura Donker Kaat, Peter Heutink, John Cornelis Van Swieten · 2006 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
72. Large-scale pathways-based association study in amyotrophic lateral sclerosis
    Dalia Kasperavičiūtė, Mike E. Weale, Kevin V. Shianna, Gareth T. Banks, Claire L. Simpson, Valerie K. Hansen, Martin R. Turner, Christopher E. Shaw, Ammar Al‐Chalabi, Hardev Pall et al. · 2007 · Brain
73. Autophagy Dysfunction in ALS: from Transport to Protein Degradation
    Marta Cozzi, Veronica Ferrari · 2022 · Journal of Molecular Neuroscience
74. The complex aetiology of frontotemporal lobar degeneration
    Stuart M. Pickering-Brown · 2007 · Experimental Neurology
75. Dictyostelium as a model for human lysosomal and trafficking diseases
    Markus Maniak · 2010 · Seminars in Cell and Developmental Biology
76. Protein clearing pathways in ALS.
    Michela Ferrucci, Fedrica Fulceri, Luca Toti, Paola Soldani, Gabriele Siciliano, Antonio Paparelli, Francesco Fornai · 2011 · PubMed
77. Coordination of synaptic vesicle trafficking and turnover by the Rab35 signaling network
    Patricia Sheehan, Clarissa L. Waites · 2017 · Small GTPases
78. Current Knowledge of Endolysosomal and Autophagy Defects in Hereditary Spastic Paraplegia
    Liriopé Toupenet Marchesi, Marion Leblanc, Giovanni Stévanin · 2021 · Cells
79. Mitochondria Dysfunction in Frontotemporal Dementia/Amyotrophic Lateral Sclerosis: Lessons From Drosophila Models
    Sharifah Anoar, Nathaniel S. Woodling, Teresa Niccoli · 2021 · Frontiers in Neuroscience
80. RNA and protein-dependent mechanisms in tauopathies: consequences for therapeutic strategies
    Jean‐Marc Gallo, Wendy J. Noble, T. Rodriguez Martin · 2007 · Cellular and Molecular Life Sciences
81. Protein recycling pathways in neurodegenerative diseases
    Faisal Fecto, Y. Taylan Esengul, Teepu Siddique · 2014 · Alzheimer s Research & Therapy
82. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)
    Nick Parkinson · 2006 · Neurology
83. Impact of Air Pollutants on Oxidative Stress in Common Autophagy-Mediated Aging Diseases
    Mohamed Numan, Jacques P. Brown, Laëtitia Michou · 2015 · International Journal of Environmental Research and Public Health
84. The role of lysosomes and autophagosomes in frontotemporal lobar degeneration
    Bain, H. D. C., Davidson, Y. S., Robinson, A. C., Ryan, S., Rollinson, S., Richardson, A., Jones, M., Snowden, J. S., Pickering‐Brown, S., Mann, D. M. A. · 2019 · Neuropathology and Applied Neurobiology
85. A transgenic mouse expressing CHMP2Bintron5mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia
    Aurélia Vernay, Ludivine Therreau, Béatrice Blot, Valérie Risson, Sylvie Dirrig‐Grosch, Robin Waegaert, Thiebault Lequeu, François Sellal, Laurent Schaeffer, Rémy Sadoul et al. · 2016 · Human Molecular Genetics
86. Plasma ATG5 is increased in Alzheimer’s disease
    Sun-Jung Cho, Hyun Joung Lim, Chulman Jo, Moon Ho Park, Changsu Han, Young Ho Koh · 2019 · Scientific Reports
87. Mucolipidosis type IV: The importance of functional lysosomes for efficient autophagy
    Silvia Vergarajauregui, Rosa Puertollano · 2008 · Autophagy
88. Mutation analyses in amyotrophic lateral sclerosis/parkinsonism–dementia complex of the Kii peninsula, Japan
    Hiroyuki Tomiyama, Yasumasa Kokubo, Ryogen Sasaki, Yuanzhe Li, Yoko Imamichi, Manabu Funayama, Yoshikuni Mizuno, Nobutaka Hattori, Shigeki Kuzuhara · 2008 · Movement Disorders
89. Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers
    Mathieu Herman, Grace W. Randall, Julia L. Spiegel, Delphina J. Maldonado, Sabrina Simoes · 2024 · Philosophical Transactions of the Royal Society B Biological Sciences
90. Autophagy and neurodegeneration: Unraveling the role of C9ORF72 in the regulation of autophagy and its relationship to ALS-FTD pathology
    Rim Diab, Federica Pilotto, Smita Saxena · 2023 · Frontiers in Cellular Neuroscience
91. Mammalian autophagosomes form from finger-like phagophores
    Claudia Puri, Matthew J. Gratian, David Chaim Rubinsztein · 2023 · Developmental Cell
92. When membranes need an ESCRT: endosomal sorting and membrane remodelling in health and disease
    Victor Alfred, Thomas Vaccari · 2016 · Swiss Medical Weekly
93. Management of Frontotemporal Dementia: Targeting Symptom Management in Such a Heterogeneous Disease Requires a Wide Range of Therapeutic Options
    Gregory A. Jicha, Peter T. Nelson · 2011 · Neurodegenerative Disease Management
94. The integration site of the APP transgene in the J20 mouse model of Alzheimer’s disease
    Justin Tosh, Matthew Rickman, Ellie Rhymes, Frances E. Norona, Emma L. Clayton, Lennart Mucke, Adrian M. Isaacs, Elizabeth Fisher, Frances K. Wiseman · 2017 · Wellcome Open Research
95. Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer’s Disease Sequencing Project
    Elizabeth Blue, Joshua C. Bis, Michael O. Dorschner, Debby W. Tsuang, Sandra Barral, Gary W. Beecham, Jennifer Elizabeth Below, William S. Bush, Mariusz Butkiewicz, Carlos Cruchaga et al. · 2018 · Dementia and Geriatric Cognitive Disorders
96. Recent advances in understanding frontotemporal degeneration
    Barbara Borroni, Alberto Benussi · 2019 · F1000Research
97. The functional analysis of the CHMP2B missense mutation associated with neurodegenerative diseases in the endo-lysosomal pathway
    Jeong Ho Han, Hyun-Hee Ryu, Mi-Hee Jun, Deok‐Jin Jang, Jin‐A Lee · 2012 · Biochemical and Biophysical Research Communications
98. Pathomechanism Heterogeneity in the Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Disease Spectrum: Providing Focus Through the Lens of Autophagy
    Rebecca Casterton, Rachel J. Hunt, Manolis Fanto · 2020 · Journal of Molecular Biology
99. GISP binding to TSG101 increases GABAB receptor stability by down‐regulating ESCRT‐mediated lysosomal degradation
    Sriharsha Kantamneni, David Holman, Kevin A. Wilkinson, Sônia A. L. Corrêa, Marco Feligioni, Simon Jack Ogden, William D. Fraser, Atsushi Nishimune, Jeremy Martin Henley · 2008 · Journal of Neurochemistry
100. Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration.
     Daniela Galimberti, Elio Angelo Scarpini · 2010 · PubMed Central